TB Biosciences

TB Biosciences, Inc. is an early stage development medical diagnostics company developing a rapid point-of-care tuberculosis test that meets performance standards around the world. The goal of TB Biosciences is to replace the current 125 year old sputum test with a simple to operate and use rapid Tuberculosis test. The Company is using an array of patented peptides developed and exclusively licensed from the NYU School of Medicine.